Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer

von Pawel, Joachim ; Jotte, Robert ; Spigel, David R ; O'Brien, Mary E R ; Socinski, Mark A ; Mezger, Jörg ; Steins, Martin ; Bosquée, Léon ; Bubis, Jeffrey ; Nackaerts, Kristiaan ; Trigo, José M ; Clingan, Philip ; Schütte, Wolfgang ; Lorigan, Paul ; Reck, Martin ; Domine, Manuel ; Shepherd, Frances A ; Li, Shaoyi ; Renschler, Markus F

Journal of clinical oncology, 2014-12, Vol.32 (35), p.4012-4019 [Periódico revisado por pares]

United States

Texto completo disponível